Epigenetic age acceleration as a biomarker of amyotrophic lateral sclerosis severity?

Epigenetic age acceleration as a biomarker of amyotrophic lateral sclerosis severity?

Saved in:

Bibliographic Details
Main Authors:	Sebastian A. Lewandowski, Lara Kular, Maja Jagodic
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396424005061
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epigenetic age acceleration is associated with occupational exposures, sex, and survival in amyotrophic lateral sclerosisResearch in context
by: Yue Zhao, et al.
Published: (2024-11-01)

Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis
by: Yongting Lv, et al.
Published: (2025-09-01)

Severity and functional ability scale for amyotrophic lateral sclerosis patients
by: Marco Antonio Orsini
Published: (2012-01-01)

Urinary P75: a promising biomarker for amyotrophic lateral sclerosis
by: Martin R Turner, et al.
Published: (2025-08-01)

MicroRNA as a Potential Biomarker for Amyotrophic Lateral Sclerosis (ALS)
by: José Augusto Nogueira-Machado, et al.
Published: (2025-05-01)

Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells.
by: Giovanni Nardo, et al.
Published: (2011-01-01)

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications
by: Farah Anjum, et al.
Published: (2025-06-01)

Genetics of familial amyotrophic lateral sclerosis
by: A. V. Savinova, et al.
Published: (2021-10-01)

Opinion: Conjugal amyotrophic lateral sclerosis
by: Roberto E. Sica, et al.
Published: (2010-04-01)

Pain in Amyotrophic Lateral Sclerosis Is Underrated
by: Soyoung Kwak, et al.
Published: (2024-12-01)

Glial Cells in Amyotrophic Lateral Sclerosis
by: Jurate Lasiene, et al.
Published: (2011-01-01)

Deontological aspects of the amyotrophic lateral sclerosis
by: T. M. Alekseeva, et al.
Published: (2018-01-01)

Management of Dysarthria in Amyotrophic Lateral Sclerosis
by: Elena Pasqualucci, et al.
Published: (2025-07-01)

Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
by: Zhouwei Xu, et al.
Published: (2016-01-01)

Epigenetic Biomarkers Driven by Environmental Toxins Associated with Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the United States: A Systematic Review
by: Melanie Engstrom Newell, et al.
Published: (2025-01-01)

Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis
by: Besnik Muqaku, et al.
Published: (2025-07-01)

Barriers in the Nervous System: Challenges and Opportunities for Novel Biomarkers in Amyotrophic Lateral Sclerosis
by: Lorena Pisoni, et al.
Published: (2025-06-01)

Presymptomatic genetic counseling in amyotrophic lateral sclerosis
by: Yu. A. Shpilyukova, et al.
Published: (2018-01-01)

Amyotrophic lateral sclerosis: considerations on diagnostic criteria
by: Marco A. Chieia, et al.
Published: (2010-12-01)

Epidemiology of amyotrophic lateral sclerosis in the Krasnoyarsk region
by: E. A. Ermilov, et al.
Published: (2024-01-01)

Clinical features of fatigue in amyotrophic lateral sclerosis
by: E. V. Pervushina, et al.
Published: (2025-04-01)

Voxel-based morphometry in amyotrophic lateral sclerosis
by: I. S. Bakulin, et al.
Published: (2019-01-01)

Amyotrophic lateral sclerosis in a tricenarian female
by: Anshul Sood, MBBS, et al.
Published: (2025-02-01)

A Successful Pregnancy with Amyotrophic Lateral Sclerosis
by: P. D. M. Pathiraja, et al.
Published: (2020-01-01)

Glutathione oxidation in cerebrospinal fluid as a biomarker of oxidative stress in amyotrophic lateral sclerosis
by: Trong Khoa Pham, et al.
Published: (2025-07-01)

MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.
by: Janne M Toivonen, et al.
Published: (2014-01-01)

Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis.
by: Paul E Young, et al.
Published: (2017-01-01)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
by: Wolfgang Becker, et al.
Published: (2019-09-01)

Advances in Mouse Models of Amyotrophic Lateral Sclerosis
by: LUO Lianlian, et al.
Published: (2025-06-01)

Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present
by: Mario Rafael Pagani, et al.
Published: (2011-01-01)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
by: Brett Morrison, et al.
Published: (2012-01-01)

An Advancements In Treatment Of Amyotrophic Lateral Sclerosis (ALS)
by: Weronika Ożóg, et al.
Published: (2025-06-01)

The Role of mTOR in Amyotrophic Lateral Sclerosis
by: José Augusto Nogueira-Machado, et al.
Published: (2025-04-01)

Major advances in amyotrophic lateral sclerosis in 2020
by: Divyani Garg, et al.
Published: (2021-01-01)

Dynamics of Onset and Progression in Amyotrophic Lateral Sclerosis
by: Michael Swash, et al.
Published: (2025-06-01)

Quality of life of patients with Amyotrophic Lateral Sclerosis
by: Sue Christine Siqueira, et al.
Published: (2017-06-01)

Quality of life of patients with Amyotrophic Lateral Sclerosis
by: Sue Christine Siqueira, et al.
Published: (2017-06-01)

Twitch force in human Amyotrophic Lateral Sclerosis
by: Laura Libonati, et al.
Published: (2025-05-01)

Fatigue in amyotrophic lateral sclerosis and correlated factors
by: Mariana Asmar Alencar, et al.
Published: (2022-10-01)

Staging model for amyotrophic lateral sclerosis in Singapore
by: Yuan Teck Tay, et al.
Published: (2022-07-01)